The economic burden of Medicare-eligible patients by multiple sclerosis type.

@article{Gilden2011TheEB,
  title={The economic burden of Medicare-eligible patients by multiple sclerosis type.},
  author={Daniel M Gilden and Joanna M Kubisiak and Arthur S. Zbrozek},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2011},
  volume={14 1},
  pages={61-9}
}
OBJECTIVE Although the global rate of multiple sclerosis (MS) is low, a few studies have documented high costs. Costs are highly variable depending on MS stage. This study was designed to assess the economic burden of Medicare-eligible patients by MS type in the United States using a claims-based classification algorithm to examine cost variation by disease… CONTINUE READING